Cutaneous desmoplastic melanoma

被引:79
作者
Busam, KJ [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
desmoplastic; melanoma;
D O I
10.1097/01.pap.0000155071.86944.a6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Desmoplastic melanoma (DM) is a fibrosing variant of spindle cell melanoma. It most often presents as an indurated lesion in chronically sun-damaged skin. Due to the lack of characteristic clinical features, early detection is uncommon. At the time of excision, the tumors usually extend into the reticular dermis or deeper. DM is prone to misdiagnosis. It may simulate histologically sclerosing melanocytic nevi as well as various benign and malignant nonmelanocytic lesions. There is significant morphologic variability among tumors classified as DM. Desmoplasia may be prominent throughout the entire tumor ("pure" DM) or represent a portion of an otherwise nondesmoplastic melanoma ("combined" DM). Some tumors show neuroma-like features with prominent nerve involvement, in which case the term "desmoplastic neurotropic melanoma" is used. Immunophenotypically, DMs are usually strongly and hornogeneously positive for S-100 protein but are often negative or only focally positive for melanocyte differentiation antigens such as tyrosinase, gp 100, Melan-A, and microplithalmia transcription factor. DM differs from conventional melanoma in its clinical course. It is associated with a higher tendency for local recurrence, but metastases to regional lymph nodes are less common. Evidence is also emerging that for patients with thick melanomas, the presence of a paucicellular fibrosing tumor histology (pure DM) is a favorable prognostic factor for survival.
引用
收藏
页码:92 / 102
页数:11
相关论文
共 62 条
[1]  
ALLAN PW, 1980, PATHOL ANNU, V15, P133
[2]   DESMOPLASTIC MALIGNANT-MELANOMA - A CLINICOPATHOLOGICAL STUDY OF 25 CASES [J].
ANSTEY, A ;
MCKEE, P ;
JONES, EW .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (04) :359-371
[3]  
Arbiser ZK, 2001, AM J CLIN PATHOL, V116, P473
[4]  
BAER SC, 1995, CANCER, V76, P2242, DOI 10.1002/1097-0142(19951201)76:11<2242::AID-CNCR2820761110>3.0.CO
[5]  
2-I
[6]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[7]  
Ballo NT, 2004, ONCOLOGY-NY, V18, P99
[8]  
BEENKEN S, 1989, ARCH OTOLARYNGOL, V115, P374
[9]   Cutaneous desmop astic melanoma - Reappraisal of morphologic heterogeneity and prognostic factors [J].
Busam, KJ ;
Mujumdar, U ;
Hummer, AJ ;
Nobrega, J ;
Hawkins, WG ;
Coit, DG ;
Brady, MS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (11) :1518-1525
[10]   Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma [J].
Busam, KJ ;
Iversen, K ;
Coplan, KC ;
Jungbluth, AA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (02) :197-204